Product Code: DLF FDA class 2 21 CFR 862.3380

Enzyme Immunoassay, Ethosuximide

Clinical Toxicology

The Enzyme Immunoassay for Ethosuximide is a laboratory test system that employs enzyme immunoassay methodology to measure ethosuximide, an anticonvulsant drug used to treat absence seizures, in patient serum or plasma. It is a Class 2 device requiring 510(k) premarket notification. The product code is DLF, regulated under 21 CFR 862.3380, within the Clinical Toxicology specialty. It is eligible for third-party 510(k) review.

510(k)s
9
FEI Numbers
1
Registration Numbers
1
Unique Applicants
5
Years Active
10

Research product code DLF in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
DLF
Device Class
FDA class 2
Regulation Number
862.3380
Medical Specialty
Clinical Toxicology
Review Panel
TX
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 9 510(k) clearances via K numbers.

K Number Device Name
K881607 EASY-TEST EMIT(R) ETHOSUXIMIDE (ETHS) ITEM 16647
K850174 TDX ETHOSUXIMIDE
K844204 EMIT QST ETHOSUXIMIDE ASSAY
K832797 MODIFICA- OF EMIT AED ETHOSUXIMIDE ASSAY
K823801 AMES TDA ETHOSUXIMIDE TEST
K823745 ADVANCE EMIT-AED ETHOSUXIMIDE
K792584 ACA ETHOSURIMIDE TEST PACK
K780461 ANALYZER-SUPPLEMENT, KINETIC, LKB 2086
K780380 ANALYZER, FAST, CENTRIFUGAL, GEMSAEC

FEI Numbers

This FDA classification entry is associated with 1 FEI number. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 1 registration number. Click on an entry to view related FDA registrations.